Author

Pascal Juillerat 1

1 Gastroenterology, Department of Visceral Surgery and Medicine, Inselspital Bern and Bern University, Bern, Switzerland

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

Fernando Gomollon Garcia, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James Lindsay, Laurent Peyrin-Biroulet, Garret Cullen, Marco Daperno, Torsten Kucharzik, Florian Rieder, Sven Almer, Alessandro Armuzzi, Marcus Harbord, Jost Langhorst, Miquel Sans, Yehuda Chowers, Gionata Fiorino, Pascal Juillerat, Geras

7Α-HYDROXY-4-CHOLESTEN-3-ONE FOR DIAGNOSIS AND MANAGEMENT OF BILE ACID MALABSORPTION: FIRST YEAR CLINICAL EXPERIENCE.

Bernhard Friedli, Felix Brunner, Christophe Prost, Cédric Bovet, Dino Kröll, Andrew Macpherson, Pascal Juillerat

7Α-HYDROXY-4-CHOLESTEN-3-ONE FOR DIAGNOSIS AND MANAGEMENT OF BILE ACID MALABSORPTION: FIRST YEAR CLINICAL EXPERIENCE.

Pascal Juillerat

ALCOHOL CONSUMPTION BEHAVIOUR AND IMPACT ON GASTROINTESTINAL SYMPTOMS AMONG SWISS IBD PATIENTS

Felix Brunner, Nicolas Fournier, Roland von Känel, Stefan Begré, Carole Clair, Andrew Macpherson, Pascal Juillerat

BENEFITS OF HIGH VERSUS LOW DOSE UPADACITINIB AS MAINTENANCE TREATMENT IN ULCERATIVE COLITIS PATIENTS WHO WERE RESPONDERS TO 8-WEEK INDUCTION WITH UPADACITINIB: RESULTS FROM THE U-ACHIEVE PHASE 3 MAINTENANCE TRIAL

Brian G. Feagan, Gareth Parkes, Pascal Juillerat, Krisztina Barbara Gecse, Xuan Yao, Wen Zhou, Huiwen Deng, Dapo Ilo, Yuri Sanchez Gonzalez, Peter D.R. Higgins

BIOLOGICALS AND SMALL MOLECULE COMBOTHERAPIES:PROMISING EXPERIENCE IN REFRACTORY IBD PATIENTS

Pascal Juillerat, Maude Martinho Grueber, Pierre Michetti

BIOLOGICS AND SMALL MOLECULES COMBOTHERAPIES: PROMISING EXPERIENCE IN REFRACTORY IBD PATIENTS

Pascal Juillerat, Maude Martinho

CD62L (L-SELECTIN) SHEDDING FOR ASSESSMENT OF FUNCTIONAL BLOCKADE OF TNF-ALPHA IN ANTI-TNF TREATED INFLAMMATORY BOWEL DISEASE PATIENTS: CLINICAL FEASIBILITY AND PERSPECTIVES.

Pascal Juillerat, Frank Seibold, Kathleen McCoy, Andrew Macpherson

ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment

Joana Torres, Stefanos Bonovas, Glen A Doherty, Torsten Kucharzik, Javier Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager, Livia Biancone, Bernd Bokemeyer, Peter Bossuyt, Johan Burisch, Paul Collins, Alaa El-Hussuna, Pierre Ellul, Cornelia Frei-Lanter, Federica Furfaro, Christian Gingert, Paolo Gionchetti, Fernando Gomollón, Marien González-Lorenzo, Hannah Gordon, Tibor Hlavaty, Pascal Juillerat, Konstantinos H. Katsanos, Uri Kopylov, Eduards Krustins, Theodore Lytras, Christian Maaser, Fernando Jose Magro Dias, John K. Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, João Sabino, Edoardo Vincenzo Savarino, Antonino Spinelli, Laurents Stassen, Mathieu Uzzan, Stephan Vavricka, Bram Verstockt, Janindra Warusavitarne, Oded Zmora, Gionata Fiorino

ETROLIZUMAB AS INDUCTION AND MAINTENANCE THERAPY IN PATIENTS WITH ULCERATIVE COLITIS PREVIOUSLY EXPOSED TO ANTI-TUMOR NECROSIS FACTOR AGENT: THE RANDOMIZED, PHASE 3 HICKORY TRIAL

Laurent Peyrin-Biroulet, Ailsa L Hart, Peter Bossuyt, Millie Long, Matthieu Allez, Pascal Juillerat, Alessandro Armuzzi, Edward V Loftus Jr, Elham Ostad-Saffari, Astrid Scalori, Young Oh, Swati Tole, Akiko Chai, Jennifer Pulley, Stuart Lacey, William Sandborn

Item 1 - 10 / 29
1
2 3